- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care & Insurance
Lilly halts late-stage testing of rheumatoid arthritis drug
February 7, 2013
Bloomberg NewsEli Lilly said it is halting testing of experimental drug tabalumab because the studies show the medicine is not effective.
The company said it expects to take a $50 million charge in the first quarter related to the research expenses from the drug.
MoreStruggling Greenwood biotech firm finds buyer
February 7, 2013
IBJ StaffElona Biotechnologies Inc., which has been struggling to repay Greenwood for more than $8 million in economic development
incentives, says it has solution to its financial problems.
MorePence rules out Medicaid expansion in current form
February 6, 2013
Associated PressGov. Mike Pence said Wednesday that he has ruled out expanding Medicaid under the federal health care law unless Indiana gets
approval to use state health savings accounts for the expansion.
MoreLilly aims to submit five new drugs for approval
February 4, 2013
J.K. WallWith Eli Lilly and Co. set to see patents expire on its best-selling drug at year’s end, it is in the company’s
interest to say its pipeline is about to produce new drugs. But the Indianapolis drugmaker may be in a position to submit
five new drugs for regulatory approval this year.
MoreCommunity taps Walgreens for health reform help
February 4, 2013
J.K. WallIn the era of health care reform, hospitals will face two new challenges: They will need to run higher-volume, lower-margin
businesses, and they’ll be on the hook financially for what patients do even when they’re not receiving health
care. Community Health Network’s new partnership with Walgreens’ Take Care Clinics is designed to help address
both issues.
MoreHealth care startups hungry for funds
February 2, 2013
J.K. WallFrustrated by up-and-down state funding for startup life sciences companies, industry leaders are talking up a plan to create
a dedicated funding stream that could total $30 million a year.
MoreLaw firm adds pharmacy practice
February 2, 2013
Hall Render Killian Heath & Lyman will draw on existing expertise within the firm to create the 10-member group.
MoreBaldwin & Lyons reports lower quarterly, annual profit
January 31, 2013
The Indianapolis-based transportation industry insurer attributed the lower earnings to smaller investment gains. Excluding
investments, quarterly profit increased due to fewer storm losses.
MoreCold medicines could face tighter limits in Indiana
January 29, 2013
Associated PressAn Indiana Senate committee has backed tougher limits on quantities consumers may buy of cold medications that can be used
to make methamphetamine.
MoreLilly's profit drops 4 percent, but beats analysts' estimates
January 29, 2013
J.K. WallPrice increases and sales gains helped Eli Lilly and Co. offset declining revenue from its former blockbuster Zyprexa in the
fourth quarter, allowing the company to beat analysts' expectations and raise its 2013 profit forecast.
MoreLife sciences consultancy plans to expand, add 38 jobs
January 29, 2013
Indianapolis-based Pearl Pathways, founded by two former Eli Lilly employees, plans to move into new space in March and add
the jobs by 2016.
MoreIndiana lawmakers advance music therapist bill
January 28, 2013
Associated PressA bill that would certify Indiana therapists who specialize in using music to treat people with autism, Alzheimer's and
other conditions is advancing in the General Assembly.
MoreMarian med school oversubscribed
January 28, 2013
J.K. WallMarian University’s College of Osteopathic Medicine—only the second medical school in Indiana—will enroll
162 students this fall, about 8 percent more than it planned.
MoreZimmer highly exposed to health-reform risk
January 28, 2013
J.K. WallShares of Zimmer Holdings Inc. have generated impressive returns of 23 percent in the past year and some 2013 product launches
could juice those results even further. But the Warsaw-based maker of orthopedic implants is also the most-exposed company
in its industry to two key elements of health care reform: the medical device tax and bundled payments.
MoreOnce-thriving drug lab in turnaround mode
January 26, 2013
J.K. WallTwo years ago, executives at AIT Laboratories “took their eye off the ball,” and watched the company’s business
plummet 29 percent in value. Now, after two years of turmoil, the drug-testing lab says it’s poised to return to the
double-digit rates of growth that made it a local star.
MoreWellPoint beats analysts' estimates with 4th-quarter profit surge
January 23, 2013
Associated Press, J.K. WallThe Indianapolis-based health insurer earned $464 million, or $1.51 per share, in the fourth quarter, a 38-percent leap from
a year ago, and topped analysts' forecasts by 8 cents per share.
MoreGreenwood seeks funds back from drugmaker with big plans
January 22, 2013
J.K. WallGreenwood-based Elona Biotechnologies Inc., which has been trying to bring a generic version of insulin to market, was declared
in default on $8.4 million in incentives from the city of Greenwood.
MorePence wants $1.5M a year for life sciences institute
January 21, 2013
J.K. WallThe Indiana Applied Research Enterprise already has received support from John Lechleiter, CEO of Indianapolis-based Eli Lilly
and Co., as a place for collaboration between academic and industrial scientists.
MoreQ&A
January 21, 2013
J.K. WallDave Reed is president of the Healthcare Business Solutions group inside Bloomington-based Cook Medical Inc.
Since 2007, his team of 18 full-time people—aided by about 60 others throughout Cook’s organization—has
worked with hospital systems, distributors of medical products and group purchasing organizations to improve the efficiency
of the business side of health care and to make sure new products contribute to that efficiency, as well as solving unmet
medical needs.
MoreShepherd Insurance agency goes on buying spree
January 21, 2013
J.K. WallThe Carmel insurance agency acquired three separate companies in a flurry of activity at the end of the year that will add
17 people to its staff.
MoreNew tool could drive down employers' health care costs
January 19, 2013
J.K. WallTen of Indiana’s largest employers—including the state of Indiana; Cummins Inc.; CNO Financial Group Inc.; Indiana,
Purdue and Butler universities; and Indiana University Health—think they have hit upon a solution.
MoreHealth insurance changes daunting for Indiana employers
January 19, 2013
Scott OlsonA portion of the Patient Protection and Affordable Care Act requiring companies in 2014 to begin offering health insurance
to more workers is causing a lot of anxiety.
MoreSHORT: Obsolete laws, regulations stifle advance of 'telehealth'
January 19, 2013
Jeffrey W. Short / Special to IBJYou might remember seeing Elroy Jetson sitting in front of a television in the Jetson home, with Astro, his trusty dog, and
Jane, his mother, at his side, while the doctor appeared on the screen providing medical care to Elroy. This scene is no longer
so futuristic.
MoreEli Lilly and Co.'s rebound bolsters endowment
January 19, 2013
Dan HumanThe value of Lilly Endowment Inc.’s principal holding—Eli Lilly and Co. stock—has increased nearly $2 billion
over the past two years, bolstering the private foundation’s philanthropic firepower after a decade of declining or
stagnant assets.
MoreLilly drug chosen for Alzheimer's prevention study
January 18, 2013
Associated PressResearchers have chosen an experimental drug by Eli Lilly and Co. for a large federally funded study testing whether it's
possible to prevent Alzheimer's disease in older people at high risk of developing it.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
First, the Athenaeum is going to have to get past the hurdle with the Lockerbie residents and the agreement that the parcel would be residential. Second, and in my opinion, this prime piece of property should include parking, PLUS, a black box theater(s), some market rate and affordable artist housing and a plan to renovate and reconfigure the second story theater. I would negotiate to add the DeHaan property surface parking lot into the development mix, place a one story surface parking garage on the DeHaan lot on the street level (for the Dehaan tenants use during the daytime) and add a second story to the garage that would become an addition to the current second story theater and then change the direction of the theater by moving the stage across the alley and on top of the DeHaan lot parking. You can add all the stage elements that are currently missing from the Athenaeum stage to make it more attractive for use by Ballet, Opera and traveling productions. Plus, the theater changes would probably help solve some of the soundproofing issues. Alas,it does not seem to be a part of the strategic plan to conduct a study to determine best use of the property. Seems like the current plan is a quick and easy move that ignores the property best use/potential and any strategic property planning for the effect on future generations.
I recall that MSA's pilings are still in the ground and hard to remove. It’s not likely any proposal will include significant underground construction/parking because of this. Start adding 2 floors of retail, 8 floors of parking and 5-10 floors of possible hotel, and/or 10-20 floors of residential, and you are at 30 floors already with possible expansion of all the uses. But then again I could be wrong.
Accoriding to their website there is no deadline to the Do Not Call list. What is this article referring to??
On what planet are they entitled to this largesse from the stockholders? These people make multi-million dollar salaries: Pay for your own personal travel.
It matters because they're already paid enormously fat salaries: Pay for your own personal travel. Being "taxed on it" isn't a valid excuse--so what? They're still being gifted a raft of luxury perks from somebody else's money on top of an enormous, lavish salary.